Disrupting TNF signaling in pancreatic cancer: A phase I/II clinical study in patients with advanced disease.

被引：0
|
作者：
Kosuri, KV [1 ]
Bekaii-Saab, T [1 ]
Bender, J [1 ]
Criswell, T [1 ]
Kane, Y [1 ]
Chidiac, T [1 ]
Young, D [1 ]
Guttridge, D [1 ]
Caligiuri, M [1 ]
Villalona-Calero, M [1 ]
机构：
[1] Ohio State Univ, James Carter Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：333S / 333S
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of docetaxel and S-I in patients with advanced gastric cancer
    Yamaguchi, K.
    Shimamura, T.
    Hyodo, I.
    Koizumi, W.
    Doi, T.
    Narahara, H.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    Munakata, M.
    Miyata, Y.
    Maeda, Y.
    Takiuchi, H.
    Nakano, S.
    Esaki, T.
    Kinjo, F.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1803 - 1808
  • [42] A Phase I/II trial of weekly gemcitabine with celecoxib and thalidomide for patients with advanced pancreatic cancer.
    Densmore, JJ
    Fox, JR
    Kannarkat, G
    Morgan, JK
    Petroni, G
    Blount, T
    Sullivan, K
    Williams, ME
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 367S - 367S
  • [43] An update of a phase I/II study of the VEGF receptor tyrosine kinase inhibitor vatalanib and gemcitabine in patients with advanced pancreatic cancer
    Kuo, T.
    Cabebe, E. C.
    Koong, A.
    Norton, J. A.
    Kunz, P. L.
    Ford, J. M.
    Kaiser, H. L.
    Rogers, J.
    Sikic, B. I.
    Fisher, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] A phase I/II study of induction oxaliplatin, 5FU chemoradiation in patients with locally advanced, unresectable pancreatic cancer
    Leung, R. C.
    Ryan, T.
    Hochster, H.
    Newman, E.
    Chandra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] A phase I/II study of PHY906 plus capecitabine (CAP) in patients (pts) with advanced pancreatic cancer (APC)
    Hoimes, C. J.
    Lamb, L.
    Ruta, S.
    Elligers, K.
    Mezes, M.
    Grant, N.
    Liu, S.
    Lacy, J.
    Cheng, Y.
    Saif, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer
    Okusaka, Takuji
    Ishii, Hiroshi
    Funakoshi, Akihiro
    Ueno, Hideki
    Furuse, Junji
    Sumii, Toshihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (09) : 557 - 563
  • [47] Phase I/II study of daily irinatecan as radiation sensitizer for locally advanced pancreatic cancer.
    Martel-Lafay, I
    Desseigne, F
    Perol, D
    Kaemmerlen, P
    Meeus, P
    Labrosse, H
    Meunier, P
    Peyrat, P
    Vincent, B
    Negrier, S
    Carrie, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 353S - 353S
  • [48] Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study
    Fegrachi, Samira
    Walma, Marieke S.
    de Vries, Jan J. J.
    van Santvoort, Hjalmar C.
    Besselink, Marc G.
    von Asmuth, Erik G.
    van Leeuwen, Maarten S.
    Rinkes, Inne H. Borel
    Bruijnen, Rutger C.
    de Hingh, Ignace H.
    Klaase, Joost M.
    Molenaar, I. Quintus
    van Hillegersberg, Richard
    EJSO, 2019, 45 (11): : 2166 - 2172
  • [49] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [50] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
12345